image

The best stocks to buy since 1993

Our latest issue will be released in 13 days, don't miss out!

Mpac Group - Resilient performance for FY21

February 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • MPAC
  • Price:
  • 540p
Ahead of results on 14 March, Mpac, the high speed packaging and automations solutions provider, said FY21 had ended well with pretax profit in-line despite the operational challenges caused by the global supply chain crisis and the impact on labour availability due to Covid-19. Mpac has made good progress on the development of the clean energy casting and unit cell assembly line on the FREYR Battery contract, won in July 2021. The project remains on track to be completed in Q3 22. Overall the group ended 2021 with a closing order book of c.£77m, +39% year-on-year and providing good coverage of FY22 forecast revenue. For the year already ended 31 December, Shore Cap forecasts pretax profit of £8.2m/eps 32.2p with £8.8m/34.5p for t ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe